XOMA Co. (NASDAQ:XOMAO) Sees Significant Growth in Short Interest
by Kim Johansen · The Markets DailyXOMA Co. (NASDAQ:XOMAO – Get Free Report) was the recipient of a large growth in short interest in the month of May. As of May 29th, there was short interest totaling 2,149 shares, a growth of 1,468.6% from the May 14th total of 137 shares. Based on an average daily volume of 4,591 shares, the days-to-cover ratio is currently 0.5 days.
XOMA Trading Up 0.0%
NASDAQ XOMAO opened at $25.37 on Wednesday. The business’s fifty day moving average is $25.44 and its 200-day moving average is $25.42. XOMA has a one year low of $24.86 and a one year high of $26.40.
About XOMA
XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.
In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.